Ausgabe 5/2009
Inhalt (12 Artikel)
Chronic myeloid leukemia in the tyrosine kinase inhibitor era: What is the best therapy?
Alfonso Quintás-Cardama, Jorge Cortes
New agents in acute myeloid leukemia: Beyond cytarabine and anthracyclines
Amir T. Fathi, Judith E. Karp
Incorporating prognostic information into treatment decisions in chronic lymphocytic leukemia
Nitin Jain, Nicole Lamanna
Radioimmunotherapy: Strategies for the future in indolent and aggressive lymphoma
Waleed Alduaij, Tim M. Illidge
Second-line treatment paradigms for diffuse large B-cell lymphomas
Catherine Thieblemont, Christian Gisselbrecht
Inside life of melanoma cell signaling, molecular insights, and therapeutic targets
Jeffrey A. Sosman, Kim A. Margolin